Gregory Makris: Factor XI Makes the Leap from OCEANIC Stroke to the ESO 2025 Update
Gregory Makris, Senior Director in Global Medical Affairs, Cardiovascular and Thrombosis at Bayer, shared on LinkedIn:
”Stroke medicine is evolving rapidly, with emerging evidence continuously informing clinical practice!
A few days after the release of the OCEANIC Stroke trial, it is great to see Factor XI making it to the European Stroke Organisation annual stroke evidence update for 2025!
There is no time to lose when it comes to preventing secondary strokes!”
Title: ESO annual stroke evidence update 2025
Authors: Diana Aguiar de Sousa, Aristeidis H Katsanos, Linxin Li, Nicolas Martinez-Majander, John McCabe, Lina Palaiodimou, Anna Ramos Pachon, Michele Romoli, Peter D Schellinger, Annaelle Zietz, Sven Poli, Melinda Roaldsen, Ashkan Shoamanesh, Marek Sýkora, Georgios Tsivgoulis
Read the Full Article on European Stroke Journal
Stay updated on all scientific advances with Hemostasis Today.
-
Apr 20, 2026, 12:09Syed Sibtain Raza: White Blood Cells – Understanding Morphology for Better Diagnosis
-
Apr 20, 2026, 11:23Bastu Odoka: Jehovah’s Witness News on Transfusion… and a Question Worth Asking
-
Apr 20, 2026, 11:15William Aird: A Physiological Approach to Anemia
-
Apr 20, 2026, 10:59Eric Topol: Is the Interferon Pathway a Key Driver of Inflammaging and Aging
-
Apr 20, 2026, 10:47Emmanuel J Favaloro: Emerging Perspectives on Extracellular Vesicles in Hemophilia
-
Apr 20, 2026, 10:21Pierpaolo Di Micco: Honored to Join the ESVM Congress in Lausanne
-
Apr 20, 2026, 08:17Heghine Khachatryan: Key Takeaways from Day 1 – WFH 2026 World Congress
-
Apr 20, 2026, 08:10Justin Nelson-Deering։ Celebrating World Hemophilia Day in Pediatric Care
-
Apr 20, 2026, 07:53Maha Othman: Students Bringing Biomedical Chemistry to Life Through a Mini Symposium